Affordable Access

Publisher Website

An Updated View of the Roles of p53 in Embryonic Stem Cells.

Authors
  • Ayaz, Gamze1
  • Yan, Hualong1
  • Malik, Navdeep1
  • Huang, Jing1
  • 1 Cancer and Stem Cell Epigenetics, Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Type
Published Article
Journal
The International Journal Of Cell Cloning
Publisher
Wiley (John Wiley & Sons)
Publication Date
Oct 21, 2022
Volume
40
Issue
10
Pages
883–891
Identifiers
DOI: 10.1093/stmcls/sxac051
PMID: 35904997
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

The TP53 gene is unarguably one of the most studied human genes. Its encoded protein, p53, is a tumor suppressor and is often called the "guardian of the genome" due to its pivotal role in maintaining genome stability. Historically, most studies of p53 have focused on its roles in somatic cells and tissues, but in the last 2 decades, its functions in embryonic stem cells (ESCs) and induced pluripotent stem cells have attracted increasing attention. Recent studies have identified p53 as a critical regulator of pluripotency, self-renewal, differentiation, proliferation, and genome stability in mouse and human embryonic stem cells. In this article, we systematically review the studies on the functions of p53 in ESCs, provide an updated overview, attempt to reconcile controversial results described in the literature, and discuss the relevance of these cellular functions of p53 to its roles in tumor suppression. Published by Oxford University Press 2022.

Report this publication

Statistics

Seen <100 times